Table 5.

Treatment of Manifestations in Individuals with Myotonic Dystrophy Type 2

Manifestation/
Concern
TreatmentConsiderations/Other
Weakness Eval & treatment per physical medicine & rehab physician, OT, or PTTo determine need for ankle-foot orthoses, wheelchairs, or other assistive devices as disease progresses
Routine physical activity & trainingTo maintain muscle strength & endurance & help control pain
Myalgia Mexilitene, gabapentin, pregabalin, NSAIDs, low-dose thyroid replacement, tricyclic antidepressantsNo single drug has been consistently effective; low-dose narcotic analgesics, when used as part of a comprehensive pain mgmt program, may help but may also → development of tolerance & escalating doses.
Myotonia Myotonia is typically mild.Mexilitene or lamotrigine may be beneficial in some cases.
Cataracts /
Epiretinal
membranes
Cataract or epiretinal membrane removal if they impair visionDirect ophthalmoscopy & slit lamp exam can underestimate the functional significance of cataracts because the alteration of vision depends on location, not just number of subcapsular opacities.
Arrhythmia/
Cardiomyopathy
Treatment per cardiologist
  • Fatal arrhythmias can occur before onset of other symptoms.
  • Defibrillators are beneficial for those w/arrhythmias; the role of pacemaker/ defibrillators in asymptomatic persons is unknown. 1
Insulin insensitivity
& type II diabetes
Treatment per endocrinologist
Thyroid
dysfunction
Thyroid hormone substitution per endocrinologistTo maintain normal thyroid hormone levels to avoid weakness & myotonic exaggeration
Hypogonadism Testosterone replacement therapyBeneficial in males w/symptomatic hypogonadism
Gastrointestinal
manifestations
Prokinetic agents (e.g., metochlopromide, tegaserod)May be beneficial in those w/postprandial abdominal pain, bloating, constipation, & diarrhea
Fatigue & daytime sleepiness Cognitive behavioral therapy & modafinil may be helpful in some cases.Evaluate for other causes (e.g., pulmonary dysfunction, ventilator insufficiency).
Vitamin D deficiency Vitamin D supplementationDeficiency may contribute to weakness & daytime sleepiness.
Sensorineural hearing impairment Consider hearing aids.

NSAIDS = nonsteroidal anti-inflammatory drugs; OT = occupational therapist; PT = physical therapist

1.

From: Myotonic Dystrophy Type 2

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2025.
Copyright © 1993-2025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2025 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.